Bloodstream infections in critically ill patients: an expert statement

JF Timsit, E Ruppé, F Barbier, A Tabah… - Intensive care medicine, 2020 - Springer
Bloodstream infection (BSI) is defined by positive blood cultures in a patient with systemic
signs of infection and may be either secondary to a documented source or primary—that is …

Comprehensive review on the anti-bacterial activity of 1, 2, 3-triazole hybrids

B Zhang - European Journal of Medicinal Chemistry, 2019 - Elsevier
Bacterial infections, caused predominately by Gram-positive and Gram-negative organisms,
are proliferation of harmful strains of bacteria on or inside the body. Hospital-acquired and …

Antibacterial activities of sulfonyl or sulfonamide containing heterocyclic derivatives and its structure-activity relationships (SAR) studies: A critical review

SK Verma, R Verma, F Xue, PK Thakur, YR Girish… - Bioorganic …, 2020 - Elsevier
The rise of drug-resistance has made the deserted clinical requirement to improve of new
classes of antibiotics agents. The development of antibacterial agents with the novel method …

Carbapenem-sparing strategies for ESBL producers: when and how

I Karaiskos, H Giamarellou - Antibiotics, 2020 - mdpi.com
Extended spectrum β-lactamase (ESBL)-producing bacteria are prevalent worldwide and
correlated with hospital infections, but they have been evolving as an increasing cause of …

Antimicrobial de-escalation as part of antimicrobial stewardship in intensive care: no simple answers to simple questions—a viewpoint of experts

JJ De Waele, J Schouten, B Beovic, A Tabah… - Intensive care …, 2020 - Springer
Antimicrobial de-escalation (ADE) is defined as the discontinuation of one or more
components of combination empirical therapy, and/or the change from a broad-spectrum to …

The role of the microbiota in the management of intensive care patients

P Szychowiak, K Villageois-Tran, J Patrier… - Annals of intensive …, 2022 - Springer
The composition of the gut microbiota is highly dynamic and changes according to various
conditions. The gut microbiota mainly includes difficult-to-cultivate anaerobic bacteria, hence …

Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients

F Barbier, S Hraiech, S Kernéis, N Veluppillai… - Annals of Intensive …, 2023 - Springer
Background Healthcare-associated infections involving Gram-negative bacteria (GNB) with
difficult-to-treat resistance (DTR) phenotype are associated with impaired patient-centered …

Antibiotic stewardship in the ICU: time to shift into overdrive

D Mokrani, J Chommeloux… - Annals of Intensive …, 2023 - Springer
Antibiotic resistance is a major health problem and will be probably one of the leading
causes of deaths in the coming years. One of the most effective ways to fight against …

Designing of a Novel Multi-Antigenic Epitope-Based Vaccine against E. hormaechei: An Intergraded Reverse Vaccinology and Immunoinformatics Approach

TH Albekairi, A Alshammari, M Alharbi, AF Alshammary… - Vaccines, 2022 - mdpi.com
Enterobacter hormaechei is involved in multiple hospital-associated infections and is
resistant to beta-lactam and tetracycline antibiotics. Due to emerging antibiotics resistance in …

The clinical and microbiological efficacy of temocillin versus cefotaxime in adults with febrile urinary tract infection, and its effects on the intestinal microbiota: a …

C Edlund, A Ternhag, GS Ståhlgren… - The Lancet Infectious …, 2022 - thelancet.com
Background Use of third-generation cephalosporins, such as cefotaxime, is associated with
an increased risk of selection for antimicrobial resistance, so alternative antibiotics need to …